On May 7, 2024, Shah Capital Management, Inc. urged Novavax, Inc. shareholders to vote against the re-election of 3 directors and opposed proposals related to executive compensation, weeks after pushing for a board shakeup at the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.97 USD | +1.89% |
|
-7.36% | +170.21% |
02/07 | Novavax Seeks Health Canada Approval for Updated Covid-19 Vaccine | MT |
02/07 | Novavax: Health Canada approves Covid 24/25 vaccine | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+170.21% | 1.82B | |
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+41.98% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Shah Capital Management Urges Shareholders to Vote Against Novavax?s Directors